Dr. Miriam Fenton brings expertise in epidemiology methods and real world data in pre and post-approval research across a variety of therapeutic areas including neurology, immunology and oncology. Miriam is the Real World Evidence lead for Multiple Sclerosis and Dermatology at Sanofi, bringing RWE solutions to various stakeholders including medical affairs, commercial, health economics and digital. Miriam has several years of experience with prospective data collection, survey methods and randomized controlled trials. Prior to joining Sanofi, Miriam worked in Real World Evidence consulting at Evidera-PPD and has held positions at the Institute for Health at Rutgers University and the Risk Management and Epidemiology group at Purdue Pharma. She received her PhD in Epidemiology from Columbia University, Mailman School of Public Health, an MPH from Brown University and a bachelor’s in psychology from the University of Pennsylvania.